• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药品不良反应报告不足的决定因素:一项系统综述

Determinants of under-reporting of adverse drug reactions: a systematic review.

作者信息

Lopez-Gonzalez Elena, Herdeiro Maria T, Figueiras Adolfo

机构信息

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Drug Saf. 2009;32(1):19-31. doi: 10.2165/00002018-200932010-00002.

DOI:10.2165/00002018-200932010-00002
PMID:19132802
Abstract

A voluntary reporting system of adverse drug reactions (ADRs) is fundamental to drug safety surveillance but under-reporting is its major limitation. This bibliographic review sought to assess the influence of personal and professional characteristics on ADR reporting and to identify knowledge and attitudes associated with ADR reporting. A systematic review was conducted using the MEDLINE and EMBASE databases. We included papers that were published in English, French and Spanish, and covered a study population made up of health professionals. In each case, the following data were extracted: study population; workplace; study type; sample size; type of questionnaire; type of scale for measuring knowledge; response rate; personal and professional factors; and knowledge and attitudes (based on Inman's 'seven deadly sins') associated with reporting. Based on a search of computerized databases, we identified a total of 657 papers in MEDLINE and 973 in EMBASE. In all, the review covered 45 papers that fulfilled the inclusion criteria. Medical specialty was the professional characteristic most closely associated with under-reporting in 76% of studies involving physicians. Other factors associated with under-reporting were ignorance (only severe ADRs need to be reported) in 95%; diffidence (fear of appearing ridiculous for reporting merely suspected ADRs) in 72%; lethargy (an amalgam of procrastination, lack of interest or time to find a report card, and other excuses) in 77%; indifference (the one case that an individual doctor might see could not contribute to medical knowledge) and insecurity (it is nearly impossible to determine whether or not a drug is responsible for a particular adverse reaction) in 67%; and complacency (only safe drugs are allowed on the market) in 47% of studies. While personal and professional factors display a weak influence, the knowledge and attitudes of health professionals appear to be strongly related with reporting in a high proportion of studies. This result may have important implications in terms of public health, if knowledge and attitudes are viewed as potentially modifiable factors.

摘要

药品不良反应(ADR)自愿报告系统是药物安全监测的基础,但漏报是其主要局限性。本文献综述旨在评估个人和专业特征对ADR报告的影响,并确定与ADR报告相关的知识和态度。使用MEDLINE和EMBASE数据库进行了系统综述。我们纳入了以英文、法文和西班牙文发表的、涵盖由卫生专业人员组成的研究人群的论文。在每种情况下,提取了以下数据:研究人群;工作场所;研究类型;样本量;问卷类型;测量知识的量表类型;回复率;个人和专业因素;以及与报告相关的知识和态度(基于英曼的“七宗罪”)。通过对计算机化数据库的检索,我们在MEDLINE中总共识别出657篇论文,在EMBASE中识别出973篇论文。该综述总共涵盖了45篇符合纳入标准的论文。在涉及医生的76%的研究中,医学专业是与漏报最密切相关的专业特征。与漏报相关的其他因素包括:95%的研究中存在无知(仅需报告严重的ADR);72%的研究中存在缺乏自信(担心因报告仅仅是疑似的ADR而显得荒谬);77%的研究中存在慵懒(拖延、缺乏兴趣或时间去找报告卡以及其他借口的综合表现);67%的研究中存在冷漠(个别医生看到的一个病例对医学知识没有贡献)和不安全感(几乎不可能确定一种药物是否应对特定的不良反应负责);以及47%的研究中存在自满(市场上只允许使用安全的药物)。虽然个人和专业因素的影响较弱,但在很大比例的研究中,卫生专业人员的知识和态度似乎与报告密切相关。如果将知识和态度视为潜在的可改变因素,这一结果可能对公共卫生具有重要意义。

相似文献

1
Determinants of under-reporting of adverse drug reactions: a systematic review.药品不良反应报告不足的决定因素:一项系统综述
Drug Saf. 2009;32(1):19-31. doi: 10.2165/00002018-200932010-00002.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
4
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
8
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
9
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

引用本文的文献

1
Pharmacovigilance in Practice: Insights into Knowledge, Attitudes, and Practices of Pharmacists and Pharmacy Technicians in Saudi Arabia.实践中的药物警戒:沙特阿拉伯药剂师和药房技术员的知识、态度及实践洞察
J Res Pharm Pract. 2025 Aug 7;14(2):50-58. doi: 10.4103/jrpp.jrpp_8_25. eCollection 2025 Apr-Jun.
2
Observational suspected adverse drug reaction profiles of fluoro-pharmaceuticals and potential mimicry of per- and polyfluoroalkyl substances (PFAS) in the United Kingdom.英国含氟药物的观察性疑似药物不良反应概况及全氟和多氟烷基物质(PFAS)的潜在模拟情况
PLoS One. 2025 Sep 2;20(9):e0331286. doi: 10.1371/journal.pone.0331286. eCollection 2025.
3

本文引用的文献

1
Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal.改善药品不良反应报告:葡萄牙药剂师中的一项整群随机试验。
Drug Saf. 2008;31(4):335-44. doi: 10.2165/00002018-200831040-00007.
2
An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.一项旨在改善医生药品不良反应报告情况的教育干预措施:一项整群随机对照试验。
JAMA. 2006 Sep 6;296(9):1086-93. doi: 10.1001/jama.296.9.1086.
3
Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
Adverse drug reaction signal detection via the long short-term memory model.
通过长短期记忆模型进行药物不良反应信号检测。
Front Pharmacol. 2025 Jun 23;16:1554650. doi: 10.3389/fphar.2025.1554650. eCollection 2025.
4
A real-world data analysis of montelukast in FDA Adverse Event Reporting System (FAERS) database.对美国食品药品监督管理局不良事件报告系统(FAERS)数据库中孟鲁司特的真实世界数据分析。
BMC Pharmacol Toxicol. 2025 Jul 1;26(1):130. doi: 10.1186/s40360-025-00959-3.
5
Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries.建立功能完善且可持续的药物警戒系统:对高、中、低收入国家药物警戒发展情况的分析
Ther Adv Drug Saf. 2025 Jun 10;16:20420986251342941. doi: 10.1177/20420986251342941. eCollection 2025.
6
Trends in adverse drug reaction reporting in eight selected countries after the implementation of new pharmacovigilance regulation in 2012: a joinpoint regression analysis.2012年实施新的药物警戒法规后八个选定国家药物不良反应报告的趋势:一项Joinpoint回归分析
Eur J Clin Pharmacol. 2025 Jun 17. doi: 10.1007/s00228-025-03862-2.
7
Understanding community pharmacists' intentions to report adverse drug reactions in Saudi Arabia: a theory of planned behavior analysis.了解沙特阿拉伯社区药剂师报告药品不良反应的意愿:一项计划行为理论分析
Front Pharmacol. 2025 May 20;16:1574412. doi: 10.3389/fphar.2025.1574412. eCollection 2025.
8
Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study.破伤风和白喉类毒素疫苗在多发性硬化症患者中的应用:一项真实世界的前瞻性、开放标签、多中心研究。
Vaccines (Basel). 2025 Apr 24;13(5):451. doi: 10.3390/vaccines13050451.
9
The Role of Adverse Event Follow-Up in Advancing the Knowledge of Medicines and Vaccines Safety: A Scoping Review.不良事件随访在增进药物和疫苗安全性知识方面的作用:一项范围综述
Drug Saf. 2025 May 20. doi: 10.1007/s40264-025-01553-6.
10
Advancing herbal medicine safety: the need for a global pharmacovigilance approach.推进草药安全性:全球药物警戒方法的必要性。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04066-2.
挪威药剂师对疑似药品不良反应报告的态度。
Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):429-34. doi: 10.1002/pds.1298.
4
Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.药品不良反应报告:马来西亚报告不足的预测因素
Pharmacoepidemiol Drug Saf. 2007 Feb;16(2):223-8. doi: 10.1002/pds.1313.
5
A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India.印度东部临床医生药品不良反应报告知识、态度及行为的调查
Drug Saf. 2006;29(7):641-2. doi: 10.2165/00002018-200629070-00009.
6
Under-reporting of adverse drug reactions : a systematic review.药品不良反应报告不足:一项系统评价
Drug Saf. 2006;29(5):385-96. doi: 10.2165/00002018-200629050-00003.
7
Adverse drug reactions reporting at a referral hospital in Zimbabwe.津巴布韦一家转诊医院的药品不良反应报告
Cent Afr J Med. 2004 Nov-Dec;50(11-12):104-7.
8
Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.药剂师态度对药品不良反应报告的影响:葡萄牙的一项病例对照研究
Drug Saf. 2006;29(4):331-40. doi: 10.2165/00002018-200629040-00004.
9
Is there still a role for spontaneous reporting of adverse drug reactions?药品不良反应自发报告是否仍有作用?
CMAJ. 2006 Jan 17;174(2):191-2. doi: 10.1503/cmaj.050971.
10
Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.医院药品不良反应自发报告的障碍与解决办法
Br J Clin Pharmacol. 2005 Dec;60(6):653-8. doi: 10.1111/j.1365-2125.2005.02504.x.